Insidermedicine in 60 - November 2 2007

Description: From California - A new glaucoma medication may improve compliance. The FDA has approved Combigan, which combines an alpha agonist and a beta-blocker. The medicine lowers IOP by 7 mmHg on average. It should not be used in those with asthma, COPD or heart block. From Wisconsin - A new study on over 1200 infants, who were followed for over a decade, shows that those who were breast fed for over 4 months had better improvement in lung volume and function. The beneficial effect, however, was not ...